Quiet wakefulness: the influence of intraperitoneal and intranasal oxytocin on sleep–wake behavior and neurophysiology in rats
Open Access
- 11 April 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 46 (7)
Abstract
Exogenous administration of the neuropeptide oxytocin exerts diverse effects on various neurobehavioral processes, including sleep and wakefulness. Since oxytocin can enhance attention to social and fear-related environmental cues, it should promote arousal and wakefulness. However, as oxytocin can attenuate stress, reduce activity, and elicit anxiolysis, oxytocin might also prime the brain for rest, and promote sleep. At present, little research has comprehensively characterized the neuropsychopharmacology of oxytocin-induced effects on sleep–wake behavior and no reconciliation of these two competing hypotheses has been proposed. This study explored the effects of oxytocin on sleep–wake outcomes using radiotelemetry-based polysomnography in adult male and female Wistar rats. Oxytocin was administered via intraperitoneal (i.p.; 0.1, 0.3 and 1 mg·kg−1) and intranasal (i.n.; 0.06, 1, 3 mg·kg−1) routes. Caffeine (i.p. and i.n.; 10 mg·kg−1) was administered as a wake-promoting positive control. To ascertain mechanism of action, pretreatment experiments with the oxytocin receptor (OXTR) antagonist L-368,899 (i.p.; 5 mg·kg−1) followed by oxytocin (i.p.; 1 mg·kg−1) were also conducted. In both male and female rats, i.p. oxytocin promoted quiet wakefulness at the cost of suppressing active wakefulness, non-rapid eye movement (NREM) and rapid eye movement (REM) sleep. Several i.p. oxytocin-induced sleep–wake effects were mediated by OXTR binding. In contrast, i.n. oxytocin did not alter most sleep–wake outcomes at any dose tested. Both i.p. and i.n. caffeine demonstrated wake-promoting effects. These findings help reconcile competing hypotheses of oxytocin-induced effects on sleep–wake behavior: i.p. oxytocin promotes quiet wakefulness—a state of restful environmental awareness compatible with both oxytocin’s anxiolytic effects and its enhancement of processing complex stimuli.Keywords
All Related Versions
Funding Information
- University of Sydney
- National Health and Medical Research Council (APP1166044, APP1092046)
This publication has 110 references indexed in Scilit:
- Behavioral and Autonomic Responses to Acute Restraint Stress Are Segregated within the Lateral Septal Area of RatsPLOS ONE, 2011
- It's More than Sex: Exploring the Dyadic Nature of Sleep and Implications for HealthPsychosomatic Medicine, 2010
- Oxytocin and the neural mechanisms regulating social cognition and affiliative behaviorFrontiers in Neuroendocrinology, 2009
- A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorderPsychoneuroendocrinology, 2009
- REM Sleep, Prefrontal Theta, and the Consolidation of Human Emotional MemoryCerebral Cortex, 2008
- Peripherally administered non-peptide oxytocin antagonist, L368,899®, accumulates in limbic brain areas: A new pharmacological tool for the study of social motivation in non-human primatesHormones and Behavior, 2007
- Interaction of sensory responses with spontaneous depolarization in layer 2/3 barrel cortexProceedings of the National Academy of Sciences, 2003
- The Female Rat’s Sleep during Oestrous CycleNeuropsychobiology, 1983
- Modification of circadian sleep rhythms by gonadal steroids and the neural mechanisms involvedBrain Research, 1980
- Experimental Designs Balanced for the Estimation of Residual Effects of TreatmentsAustralian Journal of Scientific Research Series A: Physical Sciences, 1949